These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3549009)

  • 21. [Cinobar, a new antimicrobial agent for the treatment of urinary infections].
    Chantrie M
    Acta Urol Belg; 1980 Apr; 48(2):293-7. PubMed ID: 7006345
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M; Yuce A; Yulug N
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.
    Seppänen J
    Drugs Exp Clin Res; 1988; 14(10):669-71. PubMed ID: 3246212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cinoxacin (Cinobac)--a new drug for urinary tract infections.
    Med Lett Drugs Ther; 1981 Jun; 23(13):57-8. PubMed ID: 7017366
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
    Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infections.
    Casellas JM; Tome G; Exeni R; Grimoldi I; Goldberg M; Farinati AE
    Pathol Biol (Paris); 1993 Apr; 41(4):385-91. PubMed ID: 8233640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinoxacin for urinary tract infections.
    Hatch K
    AUAA J; 1983; 3(3):10-1. PubMed ID: 6226270
    [No Abstract]   [Full Text] [Related]  

  • 29. Cinoxacin (Cinobac) for urinary tract infections.
    Drug Ther Bull; 1980 Jun; 18(12):47-8. PubMed ID: 6993169
    [No Abstract]   [Full Text] [Related]  

  • 30. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.
    Sisca TS; Heel RC; Romankiewicz JA
    Drugs; 1983 Jun; 25(6):544-69. PubMed ID: 6347618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of urinary tract infections. Clinical experience comparing norfloxacin to other quinolones].
    Fischetti G; Stillitani E; Michetti P; Massa P; Mastroberardino G
    Minerva Urol Nefrol; 1990; 42(4):211-3. PubMed ID: 2095636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of postoperative urinary infections in obstetrics and gynecology with cinoxacin].
    Bardi M; Manzoni A
    Clin Ter; 1988 Nov; 127(3):185-8. PubMed ID: 2976355
    [No Abstract]   [Full Text] [Related]  

  • 39. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections.
    Gulsun S; Oguzoglu N; Inan A; Ceran N
    Saudi Med J; 2005 Nov; 26(11):1755-8. PubMed ID: 16311661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of cinoxacin in acute simple cystitis].
    Inaba T; Watanabe H; Ohe H
    Hinyokika Kiyo; 1986 Feb; 32(2):293-6. PubMed ID: 3524157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.